Clinical Trial Update: Phase Ib/IIa Clinical Trial of SIBP-A16 Injection in Premature Infants and Full-term Infants [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib/IIa trial evaluating SIBP-A16 Injection in premature and full-term infants for respiratory syncytial virus infection; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• SIBP-A16 Injection

Snippet

Sponsor: Shanghai Institute Of Biological Products | Conditions: Respiratory Syncytial Virus (RSV) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING